Litcius/Paper detail

Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

Antonios Kritikos, Julien Poissy, Antony Croxatto, Pierre–Yves Bochud, Jean‐Luc Pagani, Frédéric Lamoth

2020Journal of Clinical Microbiology27 citationsDOIOpen Access PDF

Abstract

= 3). In 10 (24%) cases, a positive BDG test result resulted in AF initiation/continuation with no further evidence of IC. A negative BDG result and AF abstention with subsequent IC diagnosis were observed in one case. The positive predictive value (PPV) of BDG was improved if testing was restricted to the algorithm's indications (80% versus 36%, respectively). However, adherence to the algorithm was low (26%), and no benefit of the intervention was observed. The BDG result had an impact on therapeutic decisions in more than half of the cases, which consisted mainly of safe AF interruption/abstention. Targeted BDG testing in high-risk patients improves PPV but is difficult to achieve in ICU.

Topics & Concepts

Invasive candidiasisIntensive care unitObservational studyMedicineTest (biology)Intensive careIntensive care medicineEmergency medicineInternal medicineAntifungalBiologyFluconazoleDermatologyPaleontologyAntifungal resistance and susceptibilityAntibiotic Use and Resistance
Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis | Litcius